Tema Oncology Etf Key Fundamental Indicators
| CANC Etf | 36.09 0.16 0.45% |
As of the 29th of January, Tema Oncology has the Risk Adjusted Performance of 0.1322, semi deviation of 1.07, and Coefficient Of Variation of 571.44. Tema Oncology technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the etf's future prices.
Tema Oncology's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Tema Oncology's valuation are provided below:Tema Oncology ETF does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Understanding Tema Oncology ETF requires distinguishing between market price and book value, where the latter reflects Tema's accounting equity. The concept of intrinsic value—what Tema Oncology's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Tema Oncology's price substantially above or below its fundamental value.
It's important to distinguish between Tema Oncology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Tema Oncology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Tema Oncology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Tema Oncology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Tema Oncology's etf what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Tema Oncology.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Tema Oncology on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Tema Oncology ETF or generate 0.0% return on investment in Tema Oncology over 90 days. Tema Oncology is related to or competes with Matthews Asia, Overlay Shares, Simplify Equity, KraneShares Electric, Pacer Funds, Amplify Lithium, and EA Series. More
Tema Oncology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Tema Oncology's etf current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Tema Oncology ETF upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.34 | |||
| Information Ratio | 0.1341 | |||
| Maximum Drawdown | 7.91 | |||
| Value At Risk | (1.76) | |||
| Potential Upside | 2.49 |
Tema Oncology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tema Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Tema Oncology's standard deviation. In reality, there are many statistical measures that can use Tema Oncology historical prices to predict the future Tema Oncology's volatility.| Risk Adjusted Performance | 0.1322 | |||
| Jensen Alpha | 0.2351 | |||
| Total Risk Alpha | 0.1466 | |||
| Sortino Ratio | 0.1503 | |||
| Treynor Ratio | 0.7404 |
Tema Oncology January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1322 | |||
| Market Risk Adjusted Performance | 0.7504 | |||
| Mean Deviation | 1.16 | |||
| Semi Deviation | 1.07 | |||
| Downside Deviation | 1.34 | |||
| Coefficient Of Variation | 571.44 | |||
| Standard Deviation | 1.5 | |||
| Variance | 2.25 | |||
| Information Ratio | 0.1341 | |||
| Jensen Alpha | 0.2351 | |||
| Total Risk Alpha | 0.1466 | |||
| Sortino Ratio | 0.1503 | |||
| Treynor Ratio | 0.7404 | |||
| Maximum Drawdown | 7.91 | |||
| Value At Risk | (1.76) | |||
| Potential Upside | 2.49 | |||
| Downside Variance | 1.79 | |||
| Semi Variance | 1.15 | |||
| Expected Short fall | (1.22) | |||
| Skewness | 0.7268 | |||
| Kurtosis | 1.47 |
Tema Oncology ETF Backtested Returns
Tema Oncology appears to be very steady, given 3 months investment horizon. Tema Oncology ETF owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the etf had a 0.18 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Tema Oncology ETF, which you can use to evaluate the volatility of the etf. Please review Tema Oncology's Coefficient Of Variation of 571.44, risk adjusted performance of 0.1322, and Semi Deviation of 1.07 to confirm if our risk estimates are consistent with your expectations. The entity has a beta of 0.34, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tema Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tema Oncology is expected to be smaller as well.
Auto-correlation | 0.69 |
Good predictability
Tema Oncology ETF has good predictability. Overlapping area represents the amount of predictability between Tema Oncology time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Tema Oncology ETF price movement. The serial correlation of 0.69 indicates that around 69.0% of current Tema Oncology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.89 |
Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.
| Competition |
Based on the recorded statements, Tema Oncology ETF has an One Year Return of 43.9%. This is much higher than that of the family and significantly higher than that of the Health category. The one year return for all United States etfs is notably lower than that of the firm.
Tema One Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tema Oncology's direct or indirect competition against its One Year Return to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Tema Oncology could also be used in its relative valuation, which is a method of valuing Tema Oncology by comparing valuation metrics of similar companies.Tema Oncology is currently under evaluation in one year return as compared to similar ETFs.
About Tema Oncology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tema Oncology ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tema Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tema Oncology ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Check out You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Understanding Tema Oncology ETF requires distinguishing between market price and book value, where the latter reflects Tema's accounting equity. The concept of intrinsic value—what Tema Oncology's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Tema Oncology's price substantially above or below its fundamental value.
It's important to distinguish between Tema Oncology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Tema Oncology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Tema Oncology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.